Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 478968-48-8 | MDL No. : | MFCD13689107 |
Formula : | C7H10N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VXHCBKUFAXDEDI-UHFFFAOYSA-N |
M.W : | 170.17 | Pubchem ID : | 54415748 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.43 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.17 |
TPSA : | 64.21 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.81 cm/s |
Log Po/w (iLOGP) : | 1.35 |
Log Po/w (XLOGP3) : | 0.74 |
Log Po/w (WLOGP) : | 0.59 |
Log Po/w (MLOGP) : | 0.18 |
Log Po/w (SILICOS-IT) : | 1.09 |
Consensus Log Po/w : | 0.79 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.41 |
Solubility : | 6.69 mg/ml ; 0.0393 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.67 |
Solubility : | 3.66 mg/ml ; 0.0215 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.84 |
Solubility : | 2.47 mg/ml ; 0.0145 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.14 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1207431-91-1 ]
Ethyl 5-bromo-3-ethoxy-1H-pyrazole-4-carboxylate
Similarity: 0.83
[ 72411-89-3 ]
4-Methoxypyrimidine-5-carboxylic acid
Similarity: 0.58
[ 1365939-36-1 ]
5-Ethoxy-1-methyl-1H-pyrazole-4-carboxylic acid
Similarity: 0.56
[ 1591827-16-5 ]
Methyl 6-chloro-3-methoxypyridazine-4-carboxylate
Similarity: 0.56
[ 304693-70-7 ]
1-(2-Methoxyethyl)-1H-pyrazole-4-carbaldehyde
Similarity: 0.55
[ 7251-53-8 ]
Ethyl 3-hydroxy-1H-pyrazole-4-carboxylate
Similarity: 0.98
[ 1207431-91-1 ]
Ethyl 5-bromo-3-ethoxy-1H-pyrazole-4-carboxylate
Similarity: 0.83
[ 51105-90-9 ]
Methyl 1H-pyrazole-4-carboxylate
Similarity: 0.83
[ 1260243-04-6 ]
Ethyl 5-amino-1H-pyrazole-4-carboxylate
Similarity: 0.80
[ 7251-53-8 ]
Ethyl 3-hydroxy-1H-pyrazole-4-carboxylate
Similarity: 0.98
[ 1207431-91-1 ]
Ethyl 5-bromo-3-ethoxy-1H-pyrazole-4-carboxylate
Similarity: 0.83
[ 51105-90-9 ]
Methyl 1H-pyrazole-4-carboxylate
Similarity: 0.83
[ 1260243-04-6 ]
Ethyl 5-amino-1H-pyrazole-4-carboxylate
Similarity: 0.80